Subheet Jain
Overview
Explore the profile of Subheet Jain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar D, Malik F, Bedi P, Jain S
Chem Pharm Bull (Tokyo)
. 2016 May;
64(5):399-409.
PMID: 27150472
In the present study, a series of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-ones were synthesised and evaluated as antiproliferative agents. The compounds were evaluated against a panel of human cancer cell lines. CH-1 exhibited significant...
2.
Khurana R, Mahajan M, Teenu , Kapoor S, Jain S, Singh B
Recent Pat Drug Deliv Formul
. 2015 Oct;
10(1):44-58.
PMID: 26427603
Natural diterpenoid taxanes and their semisynthetic analogues have already made an indelible mark in the chemotherapeutic world for treating various kinds of malignancies. However, due to the absence of any...
3.
Kumar D, Nepali K, Bedi P, Kumar S, Malik F, Jain S
Anticancer Agents Med Chem
. 2015 Mar;
15(6):793-803.
PMID: 25783964
4,6-diarylpyrimidones as constrained chalcone analogues have been synthesised in the present study. The synthesised compounds were evaluated against a panel of human cancer cell lines. Striking selectivity was displayed by...
4.
Puri R, Jain S
Anticancer Drugs
. 2012 Aug;
23(9):923-34.
PMID: 22926258
5-Fluorouracil (5-FU) is an anticancer drug and is considered a gold standard for the treatment of skin cancer. At present, topical chemotherapy with 5-FU is associated with the limitations of...
5.
Utreja P, Jain S, Yadav S, Khandhuja K, Tiwary A
Curr Drug Saf
. 2012 Mar;
6(5):329-38.
PMID: 22424541
Purpose: In the present study, Cremophor EL free paclitaxel elastic liposomal formulation consisting of soya phosphatidylcholine and biosurfactant sodium deoxycholate was developed and optimized. The toxicological profile, antitumor efficacy and...
6.
Utreja P, Jain S, Tiwary A
Drug Deliv
. 2011 Nov;
19(1):11-20.
PMID: 22074176
The present study examines the acute, sub-acute toxicity, and cytotoxicity of paclitaxel elastic liposomal formulation in comparison to a marketed Cremophor EL (polyoxyethylated castor oil):ethanol (1:1, v/v) based formulation. In...
7.
Utreja P, Jain S, Tiwary A
Drug Deliv
. 2011 Mar;
18(5):367-76.
PMID: 21428706
In the present study an elastic liposomes-based paclitaxel formulation was developed with the objective to remove Cremophor EL. Cremophor EL is currently used for solubilizing paclitaxel in the marketed formulation...
8.
Kaur G, Jain S, Tiwary A
Sci Pharm
. 2010 Dec;
78(1):57-78.
PMID: 21179370
The present study was aimed at evaluating the possible use of inter polymer complexed (IPC) films of chitosan (CH) and carboxymethyl tamarind kernel powder (CMTKP) for colon release of budesonide....
9.
Jain S, Kaur A, Puri R, Utreja P, Jain A, Bhide M, et al.
Eur J Med Chem
. 2010 Sep;
45(11):4997-5005.
PMID: 20805013
In the present study, an attempt was made to study the acute and sub-acute toxicity profile of G3-COOH Poly (propyl ether imine) [PETIM] dendrimer and its use as a carrier...
10.
Singh H, Tiwary A, Jain S
Yakugaku Zasshi
. 2010 Mar;
130(3):397-407.
PMID: 20190524
In the present study, an attempt was made to develop a cyclodextrin-colchicine complex and to study its effect on skin permeation and deposition of colchicine. Colchicine beta cyclodextrin (BCD) complex...